These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28083765)

  • 1. An introduction to CKD-MBD research: restart for the future.
    Fukagawa M; Inaba M; Yokoyama K; Shigematsu T; Ando R; Miyamoto KI;
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):1-3. PubMed ID: 28083765
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral metabolism in chronic kidney disease.
    Kochanek M; Said A; Lerma EV
    Dis Mon; 2015 Oct; 61(10):425-33. PubMed ID: 26518114
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Clin Calcium; 2009 Apr; 19(4):486-92. PubMed ID: 19329826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric CKD-MBD: existing and emerging treatment approaches.
    Ayoob RM; Mahan JD
    Pediatr Nephrol; 2022 Nov; 37(11):2599-2614. PubMed ID: 35038008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone kidney interactions.
    Nickolas TL; Jamal SA
    Rev Endocr Metab Disord; 2015 Jun; 16(2):157-63. PubMed ID: 26156535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic kidney disease and nutrition].
    Yoshida T; Kumagai H
    Clin Calcium; 2016 Mar; 26(3):369-74. PubMed ID: 26923973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral metabolism and cardiovascular disease in CKD.
    Fujii H; Joki N
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):53-63. PubMed ID: 28062938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
    Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
    Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women and CKD-mineral and bone disorder.
    Ho LT; Sprague SM
    Adv Chronic Kidney Dis; 2013 Sep; 20(5):423-6. PubMed ID: 23978548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research on kidney and mineral metabolism in Japan: past, present, and future.
    Mizobuchi M; Ogata H; Koiwa F; Kinugasa E; Akizawa T
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):4-8. PubMed ID: 28005175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CKD-MBD in all CKD stages: integration of basic and clinical research].
    Hamano T
    Nihon Jinzo Gakkai Shi; 2015; 57(8):1331-41. PubMed ID: 26817162
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe bone and mineral disease in an adolescent with chronic kidney disease: a case from the 70s?
    Gomes C; Dias FM; Franco L; Almeida M
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26443096
    [No Abstract]   [Full Text] [Related]  

  • 13. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic kidney disease--mineral and bone disorder: why and how to control phosphate].
    Pavlović D; Katicić D; Josipović J
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():64-7. PubMed ID: 23513419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of phosphorus load in CKD patients.
    Taketani Y; Koiwa F; Yokoyama K
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):27-36. PubMed ID: 27896453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of mineral bone disorder with pharmaceuticals which influence the calcium phosphor turnover].
    Vestergaard P; Eiken PA
    Ugeskr Laeger; 2012 Nov; 174(47):2931-4. PubMed ID: 23171790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic kidney disease (CKD) and bone. From renal osteodystrophy to CKD-MBD: new disease entity].
    Tsukamoto Y
    Clin Calcium; 2009 Apr; 19(4):479-84. PubMed ID: 19329825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New Developments in CKD-MBD. How to "Thinking Global! Acting Local" for treating CKD-MBD].
    Tsukamoto Y
    Clin Calcium; 2014 Dec; 24(12):1757-61. PubMed ID: 25423919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Introduction.
    Torregrosa JV; Bover J; Cannata Andía J
    Nefrologia; 2011; 31 Suppl 1():1-2. PubMed ID: 21468160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.